Recent articles
6 Healthcare Stocks That Could Make You Filthy Rich
These top growth stocks could dramatically improve your financial wellbeing.
Is Canopy Growth the Best Pot Stock to Buy Right Now?
Canopy may now be firmly on the path toward becoming a titan of the global cannabis industry.
Is Inovio Pharmaceuticals a Screaming Buy?
Investors may want to think twice before buying this vaccine stock on the heels of the COVID-19 threat.
Better Buy: GlaxoSmithKline vs. Bristol-Myers Squibb
Which of these top pharma stocks is the better buy right now?
Don't Buy Aurora Cannabis Stock Until These 3 Things Happen
Aurora has a tough road ahead.
Why Novavax Stock Is Marching Higher Today
Here's why it has officially doubled in value since the start of 2020.
3 Biotech Stocks That Made Early Shareholders Millionaires
Amgen, Biogen, and Gilead Sciences have each transformed their early investors.
Is Gilead Sciences an Acquisition Target?
Gilead's depressed valuation has been sparking acquisition rumors.
Better Buy: Pfizer vs. AbbVie
Which of these highly coveted dividend stocks is the best choice right now?
Could These 5 Stocks Benefit From the Coronavirus Outbreak?
These five biotechs are likely to remain on the volatile side this week, thanks to the novel-coronavirus threat.
2 Top Biotech Stocks to Buy Right Now
These companies could crush the broader markets this year.
Aurora Cannabis and Canopy Growth: Avoid These 2 Pot Stocks This Week
Earnings season may not be kind to the shareholders of either Aurora Cannabis or Canopy Growth. Here's why.
3 Top Biotech Stocks to Buy in February
These three clinical-stage biotechs could all double in value before year's end.
Why Aurora Cannabis Is Getting Hammered Today
Aurora's embattled CEO Terry Booth plans to step down.
Why PTC Therapeutics Stock Is Plummeting Today
Investors are showing their displeasure with the biotech's latest clinical update.
2 Ultra-Risky Stocks That Could Make You Filthy Rich
Aurora Cannabis and CRISPR Therapeutics have the potential to deliver million-dollar paydays for early bird investors.
2 Best Cannabis Stocks to Buy in February
These two Canadian pot stocks might be worth adding to your portfolio this month.
Is Merck's Decision to Slim Down a Buying Opportunity?
It wasn't a big hit with investors on Wednesday.
Why Clovis Oncology Stock Is Popping Today
It could be a top buyout target soon.
Gilead Sciences: Patience Required
Gilead's latest financial results may be ho-hum, but better days aren't far off.